Genomic Surveillance for SARS-CoV-2 Variants of Concern from Imported COVID-19 Cases - the Mainland of China, 2021.

Feng, Yenan; Zhao, Xiang; Chen, Zhixiao; Nie, Kai; Yin, Zeyuan; Xia, Ying; Wang, Ji; Niu, Peihua; A, Ruhan; Li, Lili; Wang, Dayan; Tan, Wenjie; Ma, Xuejun; Wang, Shiwen; Wang, Huanyu; Gao, George F; Chen, Cao; Xu, Wenbo

Feng, Yenan; Zhao, Xiang; Chen, Zhixiao; Nie, Kai; Yin, Zeyuan; Xia, Ying; Wang, Ji; Niu, Peihua; A, Ruhan; Li, Lili; Wang, Dayan; Tan, Wenjie; Ma, Xuejun; Wang, Shiwen; Wang, Huanyu; Gao, George F; Chen, Cao; Xu, Wenbo.

Afiliação

Feng Y; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhao X; National Health Commission Key Laboratory for Medical Virology and Viral Diseases, Beijing, China.
Chen Z; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Nie K; National Health Commission Key Laboratory for Medical Virology and Viral Diseases, Beijing, China.
Yin Z; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Xia Y; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Wang J; National Health Commission Key Laboratory for Medical Virology and Viral Diseases, Beijing, China.
Niu P; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
A R; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Li L; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Wang D; National Health Commission Key Laboratory for Medical Virology and Viral Diseases, Beijing, China.
Tan W; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Ma X; National Health Commission Key Laboratory for Medical Virology and Viral Diseases, Beijing, China.
Wang S; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Wang H; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Gao GF; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Chen C; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Xu W; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

China CDC Wkly ; 4(31): 680-684, 2022 Aug 05.

Article em En | MEDLINE | ID: mdl-36059791

Palavras-chave

Genomic surveillance; SARS-CoV-2; Variants of concern

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies / Screening_studies Idioma: En Revista: China CDC Wkly Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google